References:
Veilleux, A., Marzo, V., & Silvestri, C. (2019). The Expanded Endocannabinoid System/Endocannabinoidome as a Potential Target for Treating Diabetes Mellitus, 1–12.
Marzo, V. D., Bifulco, M., & Petrocellis, L. D. (2004). The endocannabinoid system and its therapeutic exploitation. Nature Reviews Drug Discovery, 3(9), 771–784.
Mechoulam, R., Hanuš, L. O., Pertwee, R., & Howlett, A. C. (2014). Early phytocannabinoid chemistry to endocannabinoids and beyond. Nature Reviews Neuroscience, 15(11), 757–764.
Cani, P. D. (2012). Crosstalk between the gut microbiota and the endocannabinoid system: impact on the gut barrier function and the adipose tissue. Clinical Microbiology and Infection, 18, 50–53.
0 comments